THE ASSOCIATION OF P2Y12 INHIBITOR COPAYMENT REDUCTION WITH OUTCOMES AT HOSPITALS WITH AND WITHOUT MEDICATION ASSISTANCE PROGRAMS

Jacob Appel Doll; Lisa Kaltenbach; Kevin Anstrom; Gregg Fonarow; Christopher Cannon; Timothy Henry; David Cohen; James Eudicone; Eileen Fonseca; Narinder Bhalla; Eric Peterson; Tracy Wang

doi:10.1016/S0735-1097(19)30803-4

Back

THE ASSOCIATION OF P2Y12 INHIBITOR COPAYMENT REDUCTION WITH OUTCOMES AT HOSPITALS WITH AND WITHOUT MEDICATION ASSISTANCE PROGRAMS

Journal article

Peer reviewed

THE ASSOCIATION OF P2Y12 INHIBITOR COPAYMENT REDUCTION WITH OUTCOMES AT HOSPITALS WITH AND WITHOUT MEDICATION ASSISTANCE PROGRAMS

Jacob Appel Doll, Lisa Kaltenbach, Kevin Anstrom, Gregg Fonarow, Christopher Cannon, Timothy Henry, David Cohen, James Eudicone, Eileen Fonseca, Narinder Bhalla, …

Journal of the American College of Cardiology, Vol.73(9), pp.195-195

2019-03

DOI: https://doi.org/10.1016/S0735-1097(19)30803-4

Metrics

3 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: THE ASSOCIATION OF P2Y12 INHIBITOR COPAYMENT REDUCTION WITH OUTCOMES AT HOSPITALS WITH AND WITHOUT MEDICATION ASSISTANCE PROGRAMS
Creators: Jacob Appel Doll
Lisa Kaltenbach
Kevin Anstrom
Gregg Fonarow
Christopher Cannon
Timothy Henry
David Cohen
James Eudicone
Eileen Fonseca
Narinder Bhalla
Eric Peterson
Tracy Wang
Publication Details: Journal of the American College of Cardiology, Vol.73(9), pp.195-195
Academic Unit: Miller School of Medicine; UMMG Dept of Neurological Surgery
Language: English
Resource Type: Journal article
Record Identifier: 991031600830902976